Singapore markets close in 4 hours 17 minutes

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
319.43+9.12 (+2.94%)
At close: 04:00PM EDT
319.43 0.00 (0.00%)
After hours: 05:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 84.48B
Enterprise value 125.41B
Trailing P/E 16.84
Forward P/E 15.67
PEG ratio (5-yr expected) 1.43
Price/sales (ttm)1.36
Price/book (mrq)N/A
Enterprise value/revenue 1.93
Enterprise value/EBITDA 9.86

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 314.87%
S&P500 52-week change 325.01%
52-week high 3335.83
52-week low 3215.96
50-day moving average 3319.79
200-day moving average 3278.64

Share statistics

Avg vol (3-month) 31.09M
Avg vol (10-day) 31.28M
Shares outstanding 5264.48M
Implied shares outstanding 6271.85M
Float 8191.28M
% held by insiders 127.22%
% held by institutions 164.96%
Shares short (28 Mar 2024) 42.6M
Short ratio (28 Mar 2024) 42.61
Short % of float (28 Mar 2024) 41.34%
Short % of shares outstanding (28 Mar 2024) 40.98%
Shares short (prior month 29 Feb 2024) 42.65M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 40.83%
Trailing annual dividend rate 32.40
Trailing annual dividend yield 30.77%
5-year average dividend yield 40.90
Payout ratio 412.65%
Dividend date 329 Mar 2024
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.07%
Operating margin (ttm)16.19%

Management effectiveness

Return on assets (ttm)11.08%
Return on equity (ttm)1,234.25%

Income statement

Revenue (ttm)64.97B
Revenue per share (ttm)238.50
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA 12.7B
Net income avi to common (ttm)5.24B
Diluted EPS (ttm)18.97
Quarterly earnings growth (yoy)-22.80%

Balance sheet

Total cash (mrq)1.02B
Total cash per share (mrq)3.86
Total debt (mrq)41.86B
Total debt/equity (mrq)3,948.96%
Current ratio (mrq)1.18
Book value per share (mrq)-6.68

Cash flow statement

Operating cash flow (ttm)9.43B
Levered free cash flow (ttm)2.87B